Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice

Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse

(2012) Nicole M. Enman et al.   BEHAVIOURAL BRAIN RESEARCH

Ketamine for Treatment-Resistant Unipolar Depression

(2012) Sanjay J. Mathew et al.   CNS DRUGS

Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine

(2012) Ming-Huan Chan et al.   SCHIZOPHRENIA RESEARCH

Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure

(2011) Nanxin Li et al.   BIOLOGICAL PSYCHIATRY

Ketamine as a Novel Antidepressant: From Synapse to Behavior

(2011) J W Murrough   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases

(2011) Amar S. et al.   CURRENT PHARMACEUTICAL DESIGN

Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice

(2011) E Beurel et al.   MOLECULAR PSYCHIATRY

Signaling pathways underlying the rapid antidepressant actions of ketamine

(2011) Ronald S. Duman et al.   NEUROPHARMACOLOGY

Roles of glutamate signaling in preclinical and/or mechanistic models of depression

(2011) Kenichi Tokita et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Social Isolation-Induced Aggression Potentiates Anxiety and Depressive-Like Behavior in Male Mice Subjected to Unpredictable Chronic Mild Stress

(2011) Xian-cang Ma et al.   PLoS One

N- methyl-D-aspartate Glutamate Receptor Antagonists and the Promise of Rapid-Acting Antidepressants

(2010) John H. Krystal   ARCHIVES OF GENERAL PSYCHIATRY

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

(2010) Nancy Diazgranados et al.   ARCHIVES OF GENERAL PSYCHIATRY

Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice

(2010) Jonathan S. Miller et al.   BRAIN RESEARCH BULLETIN

The involvement of GSK3β in bipolar disorder: Integrating evidence from multiple types of genetic studies

(2010) J.J. Luykx et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine

(2010) Kenji Hashimoto   Expert Review of Neurotherapeutics

The role of glutamate on the action of antidepressants

(2010) Kenji Hashimoto   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

(2010) N. Li et al.   SCIENCE

Glutamatergic Modulators: The Future of Treating Mood Disorders?

(2010) Carlos Zarate et al.   HARVARD REVIEW OF PSYCHIATRY

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

(2009) Rodrigo Machado-Vieira et al.   BIPOLAR DISORDERS

Emerging role of glutamate in the pathophysiology of major depressive disorder

(2009) Kenji Hashimoto   BRAIN RESEARCH REVIEWS

Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling

(2009) Yingwei Mao et al.   CELL

Cocaine-induced hyperactivity and sensitization are dependent on GSK3

(2009) Jonathan S. Miller et al.   NEUROPHARMACOLOGY

Ketamine and the next generation of antidepressants with a rapid onset of action

(2009) Rodrigo Machado-Vieira et al.   PHARMACOLOGY & THERAPEUTICS

Glutamate-based antidepressants: 20 years on

(2009) Phil Skolnick et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response

(2008) Wolfgang Block et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

(2008) Gerard Sanacora et al.   NATURE REVIEWS DRUG DISCOVERY

Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice

(2008) Angelo O. Rosa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY